Download FREE Report Sample
Download Free sampleHuman blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Fractionated Plasma s Market contains market size and forecasts of Fractionated Plasma Products in Global, including the following market information:
Global Fractionated Plasma Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fractionated Plasma Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Coagulation Factor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fractionated Plasma Products include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Fractionated Plasma Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fractionated Plasma Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fractionated Plasma Products Market Segment Percentages, by Type, 2021 (%)
Coagulation Factor
Immune Globulin
Albumin
Other
Global Fractionated Plasma Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fractionated Plasma Products Market Segment Percentages, by Application, 2021 (%)
Immunology
Hematology
Other
Global Fractionated Plasma Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fractionated Plasma Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fractionated Plasma Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fractionated Plasma Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
